drugset / Trial / NCT01201538

A Study of Nilotinib in Growing Vestibular Schwannomas

NCT01201538

NaSingle-groupOpen-labelTreatment

Summary

Acoustic Neuromas (otherwise known as Vestibular Schwannoma -VS) are benign tumors which grow on the hearing nerve and can cause progressive hearing loss and compression of vital brain structures and even death if it continues. The primary objective of this study is to evaluate the efficacy of Nilotinib in the treatment of patients with progressing VS. Secondary objectives of this study is to evaluate the toxicity profile, quality of life and symptom management of Nilotinib in the treatment of patients with progressing VS.

Timeline

Start
2010-10
Primary completion
2011-10
Completion
2013-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Nilotinib Small molecule

Indications